
The DHSC, along with a UK government department and Wellcome, aims to tackle urgent infectious disease threats

The funding will run until 2035 and will help the organisation to expand its presence in Europe

The UK government has also agreed to award the company a grant of up to £129m

The company is the latest major drugmaker to announce a significant investment in the country

The commitment marks a 25% increase to the company's US investments in the past four years

The commitment is part of the company’s ambition to achieve $80bn in total revenue by 2030

They have highlighted the importance of expanding research to entire families of pathogens

The collaboration will support solutions to address the health impacts of climate change, infectious diseases and AMR

The Paddington site will serve as one of the company’s three global hubs

According to WHO, the infectious disease was estimated to affect 10.6 million people in 2022

The ABPI highlights four key areas where the budget could boost UK life sciences

The $500m Reaching the Last Mile Fund will reach an additional 32 countries